Skip to main content
OpenTrials
Completed

NCT Number: NCT02442401

Role of Negative Pressure Wound Therapy in Latissimus Dorsi Flap Donor Site Seroma Prevention

The use of NPWT as a post-operative dressing significantly reduces the incidence of seroma formation after harvesting LD flap.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

NPWT Breast Reconstruction Latissimus Dorsi Flap

Age range

20 year–60 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 1

About this study

NPWT was left in place on donor site with constant pressure between -125 and -80 mmHg to reduce seroma formation

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age between 20-60 years Underwent breast reconstruction with LD Flap

Exclusion criteria

  • Locally advanced cancer

Treatment and study plan

The negative pressure wound therapy

Device

Other names: NPWT

Primary outcomes

  1. Incidence of seroma

    Time frame: 3 months

Secondary outcomes

  1. Aspirated Volume

    Time frame: 3 months

  2. Frequency of Aspiration

    Time frame: 3 months

Sponsors and collaborators

Lead sponsor

Chulalongkorn University

Other

Collaborators

  • Poonpissamai Suwajo
  • Pornthep Pungrasmi
  • Thana Laopiyasakul

Registry information

Important dates

Study start
2009
Primary completion
2012
Study completion
2012
First posted
May 13, 2015
Registry last updated
May 15, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.